Life Science & Chemical Instrumentation Market - Growth, Trends, and Forecasts (2020 - 2025)

• Chromatography is an analytical instrument that measures the content of various analytes in a given sample, and in many cases helps to quantify the analyte. Chromatography is mostly done to analyze compounds that can are in a liquid state, and in case of gas chromatography (GC), the analytes can be vaporized without decomposition.
• It is widely used to test the purity of substances or to separate a mixture into its basic components. Chromatography has a profound use in analytical chemistry, owing to its ability to offer excellent features, like accurate separation capabilities, reproducibility, and quicker separation. Chromatography method is used in many pharmaceutical applications, such as identifying the amount of chemical in drugs
• The increased use of chromatography tests in drug approvals and rising support from the government in the form of funds are considered to contribute to the market growth over the forecast period.
• For instance, in August 2019, ThermoFisher Scientific expanded the analytical instrument portfolio of the US FDA class I medical devices for clinical diagnostic laboratories, which now include Vanquish MD High Performance Liquid Chromatography system, TSQ Altis MD Series mass spectrometer, and Quantis MD Series mass spectrometer for routine testing

In North America, chemical instrumentation technology is used in many applications. Chemical instrumentation has proven to be an effective technology for final production testing, pharmaceutical applications, environmental monitoring, and food testing, among others. Other factors propelling the growth of North America life science and chemical instrumentation market, include increasing need for drug discovery, rising prevalence of chronic diseases, and augmented demand for rising food safety concerns. Moreover, the increasing focus on the development of new and improved drug assessment techniques, to discover highly complex drugs, has played a vital role in the evolution of innovative chemical methods in the region, which further drives the North America life science and chemical instrumentation market. For instance, in March 2020, Agilent introduced the next-generation clinical edition triple quadrupole LC/MS system, the K6460S, which is listed as a Class I medical device with the US Food and Drug Administration. This system is designed to improve the workflows in clinical labs.